DiaGenic, GE Healthcare to Develop Test for Mild Cognitive Impairment | IVD Technology

Links shared publicly online about this topic.

0
total visits

DiaGenic, GE Healthcare to Develop Test for Mild Cognitive Impairment | IVD Technology

DiaGenic ASA announced a research agreement to collaborate with GE Healthcare to develop a blood-based test using DiaGenic’s peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer’s Disease. The study would be used in conjunction with PET imaging to identify a blood based gene expression signature in these patients.

View full resource at ivdtechnology.com

Tags: Alzheimer's Disease, Disease and Condition, Healthcare, Genes, Pet, disease